Your browser doesn't support javascript.
loading
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series.
Ten Hagen, Alexander; Habermann, Elisa; Hermann, Sandra; Burmester, Gerd R; Biesen, Robert; Albach, Fredrik N.
Affiliation
  • Ten Hagen A; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität, Berlin, Germany.
  • Habermann E; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität, Berlin, Germany.
  • Hermann S; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität, Berlin, Germany.
  • Burmester GR; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität, Berlin, Germany.
  • Biesen R; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität, Berlin, Germany.
  • Albach FN; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität, Berlin, Germany fredrik.albach@charite.de.
RMD Open ; 8(2)2022 12.
Article in En | MEDLINE | ID: mdl-36597976
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatic Diseases / COVID-19 Limits: Humans Language: En Journal: RMD Open Year: 2022 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatic Diseases / COVID-19 Limits: Humans Language: En Journal: RMD Open Year: 2022 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido